What does Kopran do?

Jul 17 2025 07:13 AM IST
share
Share Via
Kopran Ltd is a micro-cap pharmaceutical and biotechnology company that manufactures finished dosage forms and bulk drugs. As of March 2025, it reported net sales of ₹1,724 Cr and a net profit of ₹97 Cr.
Overview:
Kopran Ltd is a pharmaceutical and biotechnology company operating in the micro-cap market, specializing in the manufacture of pharmaceutical finished dosage forms and bulk drugs.

History:
Kopran Ltd was incorporated on April 26, 1958. The company went public in November 1992 to finance its backward integration project for producing drug intermediates and to expand its antibiotic facility. The latest quarterly results reported net sales and profit for March 2025.

Financial Snapshot:
Net Sales: 1,724 Cr (Quarterly Results - Mar 2025)
Net Profit: 97 Cr (Quarterly Results - Mar 2025)
Market Cap: INR 866 Cr (Micro Cap)

Key Metrics:
P/E: 23.00
Industry P/E: 37
Dividend Yield: 1.67%
Debt Equity: 0.24
Return on Equity: 7.44%
Price to Book: 1.67

Contact Details:
Address: Parijat House 1076, Dr E Moses Road Worli Mumbai Maharashtra : 400018
Tel: 91-22-43661111
Email: investors@kopran.com
Website: http://www.kopran.com
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News